1. Home
  2. VERB vs HEPA Comparison

VERB vs HEPA Comparison

Compare VERB & HEPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERB
  • HEPA
  • Stock Information
  • Founded
  • VERB 2014
  • HEPA 2013
  • Country
  • VERB United States
  • HEPA United States
  • Employees
  • VERB N/A
  • HEPA N/A
  • Industry
  • VERB Other Consumer Services
  • HEPA Biotechnology: Pharmaceutical Preparations
  • Sector
  • VERB Consumer Discretionary
  • HEPA Health Care
  • Exchange
  • VERB Nasdaq
  • HEPA Nasdaq
  • Market Cap
  • VERB 4.7M
  • HEPA 4.1M
  • IPO Year
  • VERB N/A
  • HEPA N/A
  • Fundamental
  • Price
  • VERB $6.01
  • HEPA $0.57
  • Analyst Decision
  • VERB Strong Buy
  • HEPA Hold
  • Analyst Count
  • VERB 1
  • HEPA 1
  • Target Price
  • VERB $100.00
  • HEPA N/A
  • AVG Volume (30 Days)
  • VERB 93.4K
  • HEPA 27.6K
  • Earning Date
  • VERB 11-05-2024
  • HEPA 11-14-2024
  • Dividend Yield
  • VERB N/A
  • HEPA N/A
  • EPS Growth
  • VERB N/A
  • HEPA N/A
  • EPS
  • VERB N/A
  • HEPA N/A
  • Revenue
  • VERB $201,000.00
  • HEPA N/A
  • Revenue This Year
  • VERB $547.62
  • HEPA N/A
  • Revenue Next Year
  • VERB $200.00
  • HEPA N/A
  • P/E Ratio
  • VERB N/A
  • HEPA N/A
  • Revenue Growth
  • VERB 415.38
  • HEPA N/A
  • 52 Week Low
  • VERB $5.05
  • HEPA $0.48
  • 52 Week High
  • VERB $184.60
  • HEPA $3.72
  • Technical
  • Relative Strength Index (RSI)
  • VERB 35.34
  • HEPA 39.66
  • Support Level
  • VERB $5.81
  • HEPA $0.48
  • Resistance Level
  • VERB $8.31
  • HEPA $0.66
  • Average True Range (ATR)
  • VERB 0.77
  • HEPA 0.06
  • MACD
  • VERB -0.18
  • HEPA -0.01
  • Stochastic Oscillator
  • VERB 12.46
  • HEPA 32.88

About VERB Verb Technology Company Inc.

Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. Available in over 60 countries and in mobile and desktop versions, it includes verbLIVE an interactive livestream eCommerce, shoppable video and webinar, verbCRM a customer relationship management, verbTEAMS a self on-boarding version of verbCRM with built-in verbLIVE and salesforce synchronization for small businesses, verbLEARN a learning management system and among others.

About HEPA Hepion Pharmaceuticals Inc.

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.

Share on Social Networks: